Cargando…
Cost Utility of Vaccination Against COVID-19 in Brazil
OBJECTIVES: The objective of this study was to evaluate the cost-utility of the Oxford, CoronaVac, and Janssen COVID-19 vaccines from the perspective of the Brazilian public health system. METHODS: A total of 3 microsimulation models were constructed with individual data to evaluate the 3 vaccines....
Autores principales: | Fernandes, Ricardo Ribeiro Alves, Santos, Marisa da Silva, Magliano, Carlos Alberto da Silva, Tura, Bernardo Rangel, Macedo, Luana Schroeder Damico Nascimento, Padila, Matheus Piccin, França, Ana Cláudia Wekmuller, Braga, Andressa Araujo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society for Health Economics and Outcomes Research. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935121/ https://www.ncbi.nlm.nih.gov/pubmed/35325693 http://dx.doi.org/10.1016/j.vhri.2022.01.009 |
Ejemplares similares
-
Brazilian breast cancer patient-reported outcomes: What really matters for these women
por: Silva, Aline Silveira, et al.
Publicado: (2022) -
Real-World Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies During the COVID-19 Pandemic
por: Murteira, Rodrigo, et al.
Publicado: (2022) -
Description of Covid-19 Cases in Brazil and Italy
por: de Souza Ferreira, Luiz Philipe, et al.
Publicado: (2020) -
Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group
por: Leahy, Joy, et al.
Publicado: (2020) -
The Role of Health Economics and Outcomes Research in Addressing Coronavirus Disease 2019 (COVID-19)
por: Mullins, C. Daniel, et al.
Publicado: (2020)